Rachel Grisham
Section Head, Ovarian Cancer · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentOvarian Cancer Section · New York Presbyterian Hospital
2012–2013
2002–2006
Research
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 587 citations
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Journal of the National Comprehensive Cancer Network · 2022 · 346 citations
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2020 · 288 citations
- CA
57 papers
- RO
36 papers
32 papers
- YS
28 papers
- WT
26 papers
- NA
25 papers
- KL
24 papers · 1 as a fellow
22 papers
Clinical trials
- 2024–2027
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2024–2031
Principal investigator · Recruiting · Phase 3
Verastem, Inc.
- 2024–2027
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2023–2027
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center